| ROESY | rotating frame Overhauser effect spectroscopy |
|---|---|
| SDE | specific dynamic effect; subdural empyema |
| TEE | thermic effect of exercise; total energy expenditure; transesophageal echocardiography; tyrosine eth... |
| TEF | thermic effect of food; thyrotroph embryonic factor; tracheoesophageal fistula; transcriptional enha... |
| TOE | tender on examination; tracheoesophageal; transesophageal echography; transferred nuclear Overhauser... |
| drug-induced tremor | <neurology, pharmacology> A drug-induced condition where there is shaking (tremor) of the extremities that is increased with purposeful movement. Drugs known to induce tremor include: theophylline, Alupent, cyclosporine, amphetamines, lithium and caffeine. (27 Sep 1997) |
|---|---|
| drug industry | That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. (12 Dec 1998) |
| drug information services | Services providing pharmaceutic and therapeutic drug information and consultation. (12 Dec 1998) |
| drug interaction | <pharmacology> A chemical or physiologic reaction that can occur when two different medications are taken together and the interaction may affect the metabolism, effectiveness or toxicity of the other. (18 Jul 2002) |
| drug labelling | Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information. (12 Dec 1998) |
| drug monitoring | The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. (12 Dec 1998) |
| drug, over-the-counter | Drug for which a prescription is not needed. (12 Dec 1998) |
| drug packaging | Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the united states, such packaging is controlled under the federal food, drug, and cosmetic act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. drug labeling is also available. (12 Dec 1998) |
| drug pathogenesis | The production of morbid symptoms by drugs. (05 Mar 2000) |
| drug, prescription | A drug requiring a prescription, a physician's order. By comparison with an over-the-counter drug. (12 Dec 1998) |
| drug psychosis | Psychosis following or precipitated by ingestion of a drug, e.g., LSD. (05 Mar 2000) |
| drug rash | Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. (12 Dec 1998) |
| drug residues | Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment. (12 Dec 1998) |
| drug resistance | The ability of bacteria and other microorganisms to withstand a drug to which they were once sensitive (and were once stalled or killed outright). (12 Dec 1998) |
| drug resistance, microbial | The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through plasmids containing resistance factors (r factors). (12 Dec 1998) |